Biotech Week Boston highlights research progress in cell and gene therapy
At Biotech Week Boston, Editor-in-Chief Samantha Black, PhD, spoke with experts in cell and gene therapy technologies. Read More
Celldom has its eye on low-cost, scalable single-cell analysis
Celldom, a startup based in Durham, NC, has developed a low-cost, high-throughput, single-cell analysis platform designed to investigate and classify rare cells associated with diseases like cancer. The company is one of 10 semifinalists in the BioTools Innovator accelerator contest. We spoke with co-founder and CEO Benjamin Yellen as part of our exclusive coverage of the competition. Read More
Quantitative image analysis provides confidence in drug development
Olga Kubassova, PhD, CEO of Image Analysis Group, spoke with about how computational analysis is improving clinical trial imaging. Read More
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter